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Ciliopathies are a group of genetic disorders caused
by a failure to form functional cilia. Due to a lack
of structural information, it is currently poorly under-
stood how ciliopathic mutations affect protein
functionality to give rise to the underlying disease.
Using X-ray crystallography, we show that the ciliop-
athy-associated centriolar protein CEP120 contains
three C2 domains. The point mutations V194A and
A199P, which cause Joubert syndrome (JS) and
Jeune asphyxiating thoracic dystrophy (JATD),
respectively, both reduce the thermostability of the
second C2 domain by targeting residues that point
toward its hydrophobic core. Genome-engineered
cells homozygous for these mutations have largely
normal centriole numbers but show reduced
CEP120 levels, compromised recruitment of distal
centriole markers, and deficient cilia formation. Our
results provide insight into the disease mechanism
of two ciliopathic mutations in CEP120, identify
putative binding partners of CEP120 C2B, and sug-
gest a complex genotype-phenotype relation of the
CEP120 ciliopathy alleles.
INTRODUCTION
Cilia are hair-like protrusions of the plasma membrane. They are
essential cellular organelles with multiple functions, such as cell
motility and liquid movement, and also play a crucial role in
several major signaling pathways. Cilia are formed when centri-
oles (basal bodies) dock against the cell membrane and extend
their peripheral microtubule array to form the ciliary axoneme.
Centrioles display a defined polarity, with microtubule minus
and plus ends marking the proximal and distal tips, respectively.
At the start of ciliogenesis, the mother centriole is converted into
a basal body via recruitment of a Golgi-derived ciliary vesicle
onto its distal end. This process, which is a prerequisite for basal
body docking, is facilitated by components of the centriole distal
appendages, including CEP164 (Graser et al., 2007a; Schmidt
et al., 2012; Tanos et al., 2013). Distal appendages have
also been implicated in removing the ciliogenesis suppressorCell Reports 23, 2805–2818,
This is an open access article undCP110 from the distal end of mother centrioles, thereby facili-
tating axoneme outgrowth (Tanos et al., 2013). Although not a
distal appendage protein per se, TALPID3, a positive regulator
of ciliogenesis, also localizes to centriole distal ends and pro-
motes ciliary vesicle formation (Kobayashi et al., 2014; Yin
et al., 2009). Thus, the distal ends of centrioles play a crucial
role in ciliogenesis; they nucleate axoneme outgrowth and har-
bor positive and negative regulators of cilia formation.
Ciliopathies are a group of human genetic diseases in which
cilia formation or function is impaired. So far, multiple mutations
in over 50 genes (Arts and Knoers, 2013; Mitchison and Valente,
2017; Novarino et al., 2011) have been identified that can give
rise to ciliopathies. These disorders frequently manifest in
diverse phenotypes. Within a given disease class, the observed
phenotypic spectrum is often broad. Furthermore, there is also
an extensive phenotypic overlap between different ciliopathies.
Different mutations within the same gene can give rise to
different ciliopathies, whereas mutations in different genes can
cause the same ciliopathy (Arts and Knoers, 2013; Coppieters
et al., 2010; Mitchison and Valente, 2017; Novarino et al., 2011).
Our understanding of how ciliopathies arise from a given mu-
tation and how mutations relate to the resulting ciliopathies is
currently limited due to several factors. First, structural informa-
tion on most of the underlying proteins is lacking, limiting our
grasp of how these mutations affect protein structure and func-
tion. Second, the cellular mechanisms by which a given cilio-
pathic mutation translates into a disease are often incompletely
understood. Third, cilia are complex cell organelles with multiple
functions and a proteome of up to 1,000 proteins (Boldt et al.,
2016; Gherman et al., 2006; Ishikawa and Marshall, 2011),
complicating functional analyses. Finally, animal models do not
always faithfully recapitulate the phenotypes observed in hu-
mans (Novarino et al., 2011).
The majority of ciliopathic mutations target components of the
cilium, but mutations in a number of centrosomal genes, such as
CEP164, TALPID3,CSPP1, PLK4, andCEP120, also cause cilio-
pathies, raising the question of how their dysfunction mechanis-
tically translates to the corresponding disease (Alby et al., 2015;
Chaki et al., 2012; Martin et al., 2014; Roosing et al., 2016; Sha-
heen et al., 2014, 2015; Tuz et al., 2014). CEP120, for example,
plays a key role in the duplication, elongation, and maturation
of centrioles, which in principle could impact the production of
a functional basal body (Comartin et al., 2013; Lin et al., 2013;
Mahjoub et al., 2010; Wu et al., 2014). Recently, two missenseMay 29, 2018 ª 2018 MRC Laboratory of Molecular Biology. 2805
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mutations (V194A and A199P) in CEP120 have been identified to
give rise to either Joubert syndrome (JS; V194A), which mani-
fests mainly neurologically, or Jeune asphyxiating thoracic dys-
trophy (JATD; A199P), which primarily affects bone development
(Roosing et al., 2016; Shaheen et al., 2015). Whereas the V194A
mutation was found only in a single patient, five patients were
identified with the A199P mutation (Roosing et al., 2016; Sha-
heen et al., 2015). Of these, four were homozygous and one
was compound heterozygous, but all died in utero or within
1 week after birth. Intriguingly, despite manifesting as different
syndromes, the V194A and A199P mutations in CEP120 map
very closely in primary sequence. Both mutations target a region
of CEP120 that is structurally and functionally uncharacterized.
A previous report (Shaheen et al., 2015) suggested that the
A199P JATD mutation might act through its effect on centriole
duplication, as patient-derived fibroblasts showed variable
numbers of centrosomes; however, in the same report, this
was not seen when the corresponding mutation was assayed
in zebrafish embryos.
Here, we demonstrate that CEP120 contains three conserved
C2 domains, structural modules often involved in protein-protein
interactions andmembrane binding, and identify several putative
proximity interactors of the middle C2 domain (C2B) of CEP120.
In vitro, the V194A and A199P ciliopathy-associated mutations
both reduce the thermostability of C2B. In cells, these mutations
decrease CEP120 levels, affect the presence of distal, but not
proximal, centriole markers and strongly impair cilia formation,
without a major impact on centriole duplication. Altogether, our
results suggest a vital role for CEP120 C2B functionality in cilio-
genesis while inferring a complex genotype-phenotype relation
of the ciliopathy-linked CEP120 alleles.
RESULTS
The N-Terminal Region of CEP120 Contains an Array of
Three C2 Domains
To address the question of how the A199P and V194Amutations
affect CEP120 function, we first elucidated the domain architec-
ture of the CEP120 region in which they are located. Bioin-
formatics analyses using profile-profile methods suggested the
presence of two C2 domains flanking this region but failed to un-
cover significant hits for the region directly affected by both mu-
tations. Thus, guided by sequence conservation and secondary
structure predictions we designed and purified recombinant
CEP120 polypeptides comprising this region and sought to
obtain their structure by X-ray crystallography. Using a polypep-
tide from Oreochromis niloticus (O.n.) (but not from Homo
sapiens [H.s.]) we obtained diffracting crystals that allowed a
structure determination at a resolution of 1.6 A˚ (Figure 1A; Tables
S1 and S2). The structure revealed a b sandwich formed by two
antiparallel four-stranded b sheets, a fold characteristic of C2
domains. In order to compare this C2 domain to the other two
putative C2 domains in CEP120, we also solved their structures
(C2A from Danio rerio and C2C from Mus musculus) to a
resolution of 1.4 A˚ and 1.9 A˚, respectively (Figure 1A; Tables
S1 and S3).
All three C2 domains of CEP120 (C2A, C2B, and C2C) adopt
the PLC d1-like topology II and are structurally similar to each2806 Cell Reports 23, 2805–2818, May 29, 2018other (root-mean-square deviation [RMSD], 2.4–2.6 A˚), with
major differences found mainly in their loop length. Analysis of
CEP120 homologs across different organisms showed that
most metazoan CEP120 proteins possess an organization with
three C2 domains that are followed in sequence by a coiled-
coil region (Figure 1A). While the linker between C2A and C2B
is short, the linker between C2B and C2C is 100 residues
long and enriched with proline and charged residues but largely
non-conserved and without predicted secondary structure
elements. Size exclusion chromatography-multi-angle light
scattering (SEC-MALS) analysis indicates that a CEP120 frag-
ment containing all three C2 domains remains monomeric and
has a much larger hydrodynamic radius than expected for a
compact globular structure of 71 kDa (Figures S1A and S1B),
consistent with an elongated conformation arising if the three
C2 domains do not associate with each other. Thus, the C2 do-
mains are probably organized in a ‘‘beads on a string’’-like
configuration.
Ciliopathy Mutations in the CEP120 C2B Domain Do Not
Strongly Perturb Its Structure
In human CEP120, both the V194A JS and the A199P JATD mu-
tations fall within the C2B domain. In our structure of C2B from
Oreochromis niloticus, the equivalent residues (V195 and A200)
point inward toward its hydrophobic core (Figure 1B), suggesting
that they play a structurally analogous role in stabilizing the C2B
fold. To further explore how these mutations affect the C2B
domain, we attempted to solve the high-resolution structures
of these mutants using X-ray crystallography. For the O.n.-
A200P mutant (equivalent to the H.s.-A199P JATD mutation),
we obtained diffraction-quality crystals that allowed a successful
structure determination to a resolution of 2.1 A˚, (Figure 1C;
Table S1). To obtain this crystal form, we introduced an addi-
tional mutation (G307S) that we found serendipitously. Residue
G307 is solvent exposed and is not strictly conserved. Further-
more, the crystal structure of O.n. CEP120 C2B G307S
(Table S1) did not reveal significant structural differences when
compared to the corresponding wild-type (WT) structure
(RMSD, 0.19 A˚ with 181 aligned residue pairs).
The CEP120 C2B (H.s.-A199P) mutant structure revealed an
overall preservation of the C2 domain fold and only subtle struc-
tural changes. In the WT structure, the O.n. A200 residue is
located at the end of b strand 1 and its side chain points inward
toward the hydrophobic interior of the domain. The replacement
of this alanine by proline causes a change in themain-chain dihe-
dral angles of the preceding residues, resulting in a local struc-
tural change (Figure 1C). In the WT structure, the main-chain
carbonyl O of O.n.-Phe199 (H.s.-Phe198) makes a main-chain/
main-chain hydrogen bond to O.n.-Gly333 (H.s.-Gly333) that
cannot be maintained in the A199P mutant due to the conforma-
tional constraints imposed by the adjacent proline residue. In the
mutant structure, the loss of this hydrogen bond is compensated
by a peptide bond flip, allowing the main-chain carbonyl O of
O.n.-Ala198 (H.s.-Ala197) to form a new hydrogen bond with
O.n.-Gly333 (H.s.-Gly333). Both A198 and F199 are involved in
forming a beta-bulge region in b strand 1, facilitating this flip.
Residues in close contact to the O.n.-A200P (H.s.-A199) side
chain are also affected by the mutation. The most significant
Figure 1. The N-Terminal Region of CEP120
Contains Three C2 Domains, the Second of
Which Is Targeted by JS (V194A) and JATD
(A199P) Mutations
(A) Domain organization of human CEP120 pro-
tein. cc, coiled-coil domain. C2A,C2B,C2C, first,
second, third C2 domain. Shown below are ribbon
representations of the corresponding C2 domain
structures from Danio rerio (C2A), O.n. (C2B), and
Mus musculus (C2C), colored in rainbow from the
N-terminus to the C-terminus. Successive b
strands in the C2 domains are labeled from
b1 to b8.
(B) Close-up view of the regions of C2B (boxed
in A) targeted by the V195A (human V194A) and
A200P (human A199P)mutation. Side chains in the
vicinity of V195 and A200 are labeled and shown
as sticks.
(C) Left: ribbon representation of a superposition
of the WT (green) and A200P (red) O.n. C2B
structure (A199P in human CEP120). Right:
close-up view of the region boxed on the left.
Residues surrounding A200/P200 are indicated by
sticks and are labeled.
See also Figures S1 and S2 and Tables S1–S3.conformational change is observed for O.n.-F244 (H.s.-F243),
the side chain of which moves to avoid a steric clash with the
bulky pyrrolidine ring of the proline. Other structural differences
between the WT and A200P mutant, in particular the conforma-
tional change in loop 1 and loop 3, are most likely caused by
different crystal-packing interactions.
The WT and mutant C2B structures were derived from O.n.
CEP120 that is 57% identical to H.s. CEP120 C2B. Comparison
of the O.n. C2B structure with a H.s. C2B homology model
(Figure S2) suggest that the residues in the vicinity to A200
(H.s.-A199) and V195 (H.s.-V194), are essentially invariant in
both species with the exception of human I196, I285 and V332
that in O.n. are substituted by V, V, and L, respectively.
To ascertain whether the subtle changes observed in the
crystal structures of the O.n. C2B A200P (H.s. A199P) mutantCell Rare relevant for the human homolog in
solution, we turned to nuclear magnetic
resonance (NMR) spectroscopy, which
enabled us to study WT and both V194A
and A199P mutant H.s. CEP120 C2B un-
der the same conditions. Backbone reso-
nances of the 13C, 15N double-labeledWT
H.s. CEP120 C2B were assigned at 30C
to increase the sensitivity of triple-
resonance experiments (Figure S3A).
TALOS secondary structure calculations
based on secondary 13C chemical shifts
confirmed the secondary structure ele-
ments predicted from the homology
modeling. Lowering the temperature in
5C steps enabled a comparison of
1H, 15N band-selective excitation short-
transient transverse relaxation-optimizedNMR spectroscopy (BEST-TROSY) spectra of WT and V194A as
well as A199P mutant H.s. CEP120 C2B at 20C using
15N-labeled samples. At this temperature, WT and mutant sam-
ples were stable over the time course of the experiments. An
overlay of WT and mutant spectra (Figure S3B) revealed the
same overall appearance, confirming that the mutants maintain
the overall C2B fold. However, mapping chemical shift perturba-
tions induced by both mutations onto our homology model of
H.s. CEP120 C2B demonstrates that a subset of signals, pre-
dominantly local to the mutations, has been perturbed (Figures
2A and 2C). These changes include residues in the region of
highest conservation of the CEP120 C2B b sandwich (Figure 2B).
We conclude that at 20C, both JS and JATD mutations in
CEP120 only subtly disturb the overall C2B fold of human
CEP120, in agreement with our crystallographic data. Additionaleports 23, 2805–2818, May 29, 2018 2807
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Figure 2. JS (V194A) and JATD (A199P) Mutations in Human CEP120 Cause Subtle Changes in the C2B Domain Structure
(A) Per-residue plot of the weighted chemical shift perturbations of the human CEP120 C2B V194A (left) and A199P mutant (right) relative to the WT protein
observed in 1H,15N BEST-TROSY NMR spectra at 20C. Gray bars indicate line-broadened peaks.
(B) Molecular surface representation of the O.n. C2B structure colored by CONSURF conservation scores from cyan (variable) to burgundy (conserved).
(C) Homology model of human CEP120 C2B as ribbon representation. The weighted chemical-shift perturbations of the human CEP120 C2B V194A (left) and
A199P mutant (right) relative to the WT protein as observed in (A) are plotted color-coded onto this model.
See also Figures S2 and S3.circular dichroism (CD) and MALS analyses of H.s. CEP120
C2B-WT, V194A, and A199P mutant at 25C or room tempera-
ture confirm that themutantsmaintain the overall fold and remain
monomeric with hydrodynamic properties identical to those of
the WT protein in solution (Figure S1C).
JS and JATDMutations Decrease the Thermostability of
the CEP120 C2B Domain
Subtle changes of a fold due to a point mutation can result in
changes in protein stability. To establish whether the JS and
JATD mutations destabilize the CEP120 C2B domain, we
analyzed the thermostability of the corresponding human re-
combinant proteins using scanning fluorimetry, which follows
changes in exposure of aromatic residues during thermal dena-
turation, and differential scanning calorimetry (DSC), which
measures global excess heat absorption during that process2808 Cell Reports 23, 2805–2818, May 29, 2018(Figure 3A). Strikingly, both mutations resulted in a strong reduc-
tion in the overall C2B stability. While the mutants showed signs
of unfolding occurring already below body temperature, the WT
protein appeared folded at the corresponding temperature
range.
To further investigate the consequences of this thermal insta-
bility in solution, NMR spectroscopy was used to probe the
CEP120 C2B domain containing the JS and JATD mutation at
a temperature interval reaching up to body temperature. 1H,
15N BEST-TROSY spectra of 15N labeled WT, V194A and
A199P H.s. CEP120 C2B were acquired at 20C, 35C, and
37C (Figure 3B). The NMR spectra obtained for the WT protein
demonstrated its structural integrity in this temperature range. In
contrast, the V194A and A199P mutants were marginally stable
at 37C with a loss of signals at increasing temperatures, prob-
ably associated with a tendency to aggregate.
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Figure 3. JS (V194A) and JATD (A199P) Mu-
tations in CEP120 Reduce the Thermosta-
bility of the C2B Domain
(A) Thermal denaturation of human CEP120 C2B
domain, WT (green), V194A (blue), and A199P (red)
monitored using changes in heat capacity (left
panel, DSC) or fluorescence (right panel, thermal
scanning fluorimetry).
(B) Temperature dependency of NMR data of the
human CEP120 C2B domain, WT, V194A, and
A199Pmutant. 1H,15N BEST-TROSYNMR spectra
of 15N-labeled WT (green), V194A (blue), and
A199P (red) human CEP120 C2B at 293K (20C),
308K (35C), and 310K (37C).
See also Figures S2 and S3.Human Cells Carrying the JS or JATD Point Mutations in
CEP120 Grow and Cycle Normally
To investigate the effect of CEP120 C2B domain mutations
in vivo, we introduced the JS (V194A) or the JATD (A199P) muta-
tion into the CEP120 gene by clustered regularly interspaced
short palindromic repeats (CRISPR) and CRISPR associated
protein (Cas9) (CRISPR-Cas9) targeting in RPE-1 human retinal
pigmented epithelial cells (Figures 4A and S4A). As centriole
loss induces a p53-dependent cell-cycle block and CEP120 is
implicated in centriole formation, p53 null RPE-1 cells were
used for these experiments (Izquierdo et al., 2014; Mahjoub
et al., 2010; Wong et al., 2015). We obtained a single homozy-
gous V194A clone, two homozygous A199P clones (hereafterCell Rcalled V194A, A199P#1, and A199P#2),
and a CEP120 null clone (DCEP120).
Controls correspond to cell clones trans-
fected with Cas9 but no guide RNAs
(hereafter called con#1 and con#2). Cell
growth, size, and cell-cycle distribution
were largely normal in the point mutants,
except for a small increase in G2 popula-
tion in A199P#1 (Figures S4B–S4D).
Neither point mutation phenocopied
DCEP120 cells, which were larger and
showed abnormal DNA content.
JS and JATD Mutations Reduce
Both Total and Centrosomal
CEP120 Protein Levels But Do Not
Preclude Centrosome Duplication
Steady-state levels of CEP120 protein
were reduced in both JS (V194A) and
JATD (A199P) cells (Figures 4B, S4E,
and S4F). This decrease was not due
to proteasome-dependent degradation,
since treatment with the proteasome in-
hibitor, MG132, failed to restore levels of
themutant proteins to that of CEP120-WT
(Figures S4E and S4F). Our structural
work suggested that the point mutations
destabilize the C2B domain of CEP120.
To test their effect on CEP120 protein sta-bility in vivo, control and mutant cells were treated with the pro-
tein synthesis blocker cycloheximide (CHX). CHX incubation
decreased, but did not abolish, expression of the point mutant
proteins despite their much-reduced starting levels (Figure 4B).
Thus, a stable pool of CEP120 exists not only in the control but
also in V194A and A199P cells, albeit its size appears smaller
in the mutants. Consistently, the majority of CEP120 protein
has been shown to be centrosomal, of which 40% did not
dynamically exchange with the cytoplasm (Mahjoub et al.,
2010). Using immunofluorescence, we next addressed whether
the centrosomal pool of CEP120 was affected by the two point
mutations (Figure 4C). Similarly to CEP120-WT, CEP120-
V194A and CEP120-A199P were present at centrosomes witheports 23, 2805–2818, May 29, 2018 2809
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Figure 4. Characterization of RPE-1 Cell Lines Homozygous for the JS (V194A) and JATD (A199P) Mutations in CEP120
(A) Gene structure of human CEP120 with indicated guide RNA used to introduce the V194A or the A199P mutation into this locus. Primers FP1 and RP1 were
used to amplify and sequence the targeted genomic region. The framed area depicts protein products corresponding to the sequences obtained from themutant
RPE-1 clones. See Figure S4A for further details.
(legend continued on next page)
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a preferential enrichment on daughter centrioles (Mahjoub et al.,
2010) (Figures 4C and S5A). However, quantification of signal
intensities revealed a reduction of40% and30% in centroso-
mal CEP120 levels in V194A and A199P cells, respectively (Fig-
ures 4D and S5B).
As CEP120 is considered essential for centriole assembly (Co-
martin et al., 2013; Lin et al., 2013;Mahjoub et al., 2010;Wu et al.,
2014), we compared centriole numbers between mutant and
control cell lines using antibodies against the proximal centriole
protein CEP152 (Lawo et al., 2012; Sir et al., 2011; Sonnen et al.,
2012) and the distal centriole marker centrin-3 (Middendorp
et al., 1997; Paoletti et al., 1996). Based on CEP152 staining,
centriole numbers were largely similar between the mutants
and the control, aside from a small increase in supernumerary
centrioles in V194A cells (Figures 5A and 5B). However, the num-
ber of centrin-3 foci was reduced in both asynchronous and
mitotic V194A cells (Figures 5C–5E). Proteins known to localize
to the proximal end of centrioles and the pericentriolar material
(PCM) such as CDK5RAP2/CEP215 and c-NAP1 (Fry et al.,
1998; Graser et al., 2007b; Lawo et al., 2012; Sonnen et al.,
2012) were detectable in the mutant centrosomes (Figures S5C
and S5D). Likewise, the PCMprotein g-tubulin localized normally
in the mutants, albeit with a 15% decrease in intensity (Fig-
ures 4E). Collectively, these data indicate that although centriole
duplication and PCM assembly are not grossly impaired in either
mutant, the distal part of centrioles may be defective, especially
in the V194A cell line.
JS and JATD Mutations in the CEP120 C2B Domain
Impede Recruitment of Centriole Distal-End Proteins
In order to decipher the impact of CEP120 ciliopathy mutations
on centriole distal ends, we assayed the localization of
CEP164, a distal appendage protein present on mother centri-
oles (Graser et al., 2007a), and that of TALPID3, a protein
enriched at the extreme distal ends of mother and daughter cen-
trioles (Kobayashi et al., 2014; Yin et al., 2009). CEP120 and
TALPID3 have been previously shown to interact (Wu et al.,
2014).
When asynchronous cells were stained with antibodies
against CEP164, the number of CEP164-positive centrosomes
was largely similar between the control and the mutants,
although 9% of V194A cells displayed no detectable signal (Fig-(B) The V194A and A199P mutations decrease steady-state levels of CEP120 in
using a polyclonal CEP120 antibody. Cell lines were treated with DMSO or the
staining; middle: western blot stained with anti-CEP120 (top) and anti-a-tubulin a
using a-tubulin bands as loading controls. n = 3 biological replicates. p values we
***p < 0.0005). Bar charts depict mean ± SD.
(C) In V194A and A199P mutant RPE-1 cells, the asymmetric localization pattern o
control cells. Control (con#1), V194A (VA), and A199P (AP#1) RPE-1 cells stai
correspond to maximum intensity projections of confocal micrographs. Insets de
(D) Quantification of total centrosomal CEP120 levels from maximum intensity pr
signal was measured in each cell within a 1.5-mm-diameter circle encompassin
signal. Swarm plot represents values from single cells with horizontal lines mark
unpaired, two-tailed Student’s t test (*p < 0.05, ****p < 0.0001). Similar results w
(E) Quantification of total centrosomal g-tubulin levels frommaximum intensity pro
in (D). Swarm plot represents values from single cells with horizontal lines marking
tailed Mann-Whitney U test (ns, not significant; ****p < 0.0001). Similar results we
See also Figures S4–S6.ures 6A and 6B). Whereas localization of CEP164 to centriole
distal ends was preserved in the mutants, its signal intensity
was reduced (Figures 6A and 6C). Similar to CEP164, TALPID3
also maintained its characteristic sub-centrosomal distribution
in the mutants. However, consistent with defects at the distal
part of centrioles, the centrosomal TALPID3 signal was reduced
by 51% in A199P and 66% in V194A cells (Figures 6D and 6E).
Based on visual inspection of 47 V194A cells, TALPID3 was ab-
sent in 9 cells and present on a single centriole in a further 18
cells. Thus, in addition to fewer centrin-3-positive foci in V194A
cells, centrosomal recruitment and/or maintenance of CEP164
and TALPID3 are impaired in V194A and A199P mutants, with
V194A cells exhibiting consistently stronger phenotypes.
CEP120 overexpression has been reported to cause exces-
sive centriole elongation in U2OS cells (Comartin et al., 2013;
Lin et al., 2013). To evaluate whether the point mutations
affected the ability of CEP120 to form such structures, FLAG-
tagged CEP120-WT, CEP120-V194A, and CEP120-A199P
were transiently overexpressed in U2OS cells. Each fusion prod-
uct was able to generate structures with an appearance consis-
tent with previous reports; these CEP120-containing filaments
are likely to correspond to elongated centrioles, as most were
associated with the PCM marker pericentrin (Figure S6A).
JS and JATD Mutations in the CEP120 C2B Domain
Impair Ciliogenesis
Lastly, we investigated whether the CEP120 point mutant centri-
oles could serve asbasal bodies to template the formationof cilia.
V194A, A199P, DCEP120, and control RPE-1 cells were serum
starved for 48–72 hr and assayed for the presence of primary cilia
and basal bodies by immunofluorescence against ARL13B and
acetylated tubulin (Figure 7A) or CEP120 and acetylated tubulin
(Figure S7A). Our results show a marked decrease in the ability
of both mutants to form cilia (Figure 7B), again with the V194A
mutant displaying a stronger defect. Given the essential roles of
CEP164 and TALPID3 in the early stages of ciliogenesis (Caja´nek
and Nigg, 2014; Graser et al., 2007a; Kobayashi et al., 2014;
Naharros et al., 2018; Oda et al., 2014; Schmidt et al., 2012;
Tanos et al., 2013), a reduction in their centrosomal pools may
contribute to poor cilia formation in the mutants (Figure 6).
Following 24 hr of serum starvation, however, a prominent cen-
trosomal CEP164 signal was detected in V194A and A199P cellsvivo. Western blot of cell lysates of control (con#1), V194A, and A199P#1 cells
protein translation inhibitor cycloheximide (CHX) as indicated. Left: Ponceau
ntibodies (bottom); right: bar chart depicts CEP120 band intensity normalized
re obtained from an unpaired, two-tailed Student’s t test (*p < 0.05, **p < 0.005,
f CEP120 is retained, but its overall centrosomal levels are lower than those in
ned by antibodies against CEP120 and the PCM protein (g-tubulin). Images
pict high (53) magnifications of selected centrosomes. Scale bars, 5 mm.
ojections obtained in the experiment shown in (C). Total CEP120 fluorescence
g the centrosome, followed by subtraction of the corresponding background
ing the median, and error bars represent SD. p values were obtained from an
ere obtained from three independent experiments.
jections obtained in experiment shown in (C). Quantification was performed as
the median, and error bars represent SD. p values were obtained from a two-
re obtained from three independent experiments.
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Figure 5. Centriole Numbers Are Preserved in JS (V194A) and JATD (A199P) Mutant RPE-1 Cells
(A) CEP152 signal intensity and distribution are comparable among control, V194A, and A199P mutant RPE-1 cell lines. Cells stained by antibodies against the
proximal centriole marker CEP152 and the nascent centriole marker HsSAS-6. Images correspond to maximum intensity projections of confocal micrographs of
control, V194A, and A199P mutant. Scale bars, 5 mm.
(B) The number of CEP152 foci per cell is similar among asynchronous control, V194A, and A199Pmutant RPE-1 cell lines. CEP152 localizes to the proximal ends
of mother and daughter centrioles, and thus, cells are expected to contain two foci from G1 until centriole disengagement in anaphase. Occasionally, an un-
favorable relative orientation, or proximity, prevents resolution of two foci.
(C) Centrin-3 signal is weak in mitotic V194A and A199P mutant RPE-1 cells. Cells arrested in mitosis by monopole-inducing STLC treatment stained by anti-
bodies against the distal centriole marker centrin-3. Images correspond to maximum intensity projections of confocal micrographs. Insets depict high (23)
magnification of centrosomes. Scale bars, 5 mm.
(D) The number of centrin-3 foci per cell is reduced in mitotic V194A mutant RPE-1 cells. Centrin-3 localizes to the distal part of centrioles, and since centriole
duplication yields two centriole pairs, cells inmitosis are expected to contain 4 centrioles. Occasionally, the orientation of centrioleswithin pairs, their proximity, or
the small size of nascent centrioles can preclude resolution of pairs, hence the categories 1–2 and 3–4 on the plot.
(E) The number of centrin-3 foci is reduced in asynchronous (non-mitotic) V194A mutant RPE-1 cells with nearly 20% of cells lacking a detectable signal.
Asynchronous cells are expected to contain 2–4 centrin-3 foci, depending on their cell-cycle stage.
See also Figures S4–S6.(Figure S7B). By contrast, although TALPID3 was present in the
basal bodies of those mutant cells that successfully templated
a cilium, the signal appeared weaker in A199P and markedly
reduced in V194A cells (Figures 7C–7E). TALPID3 was present
on both centrioles in 39 out of 40 serum-starved control cells,2812 Cell Reports 23, 2805–2818, May 29, 2018whereas a single TALPID3 focus was detected in 4 out of 32
A199P and 9 out of 30 V194A cells, with TALPID3 being absent
in 5V194Acells. Thus, the number of TALPID3-positive centrioles
is lower both in cycling and serum-starved V194A cells. Removal
of the centriole-capping protein CP110 from the distal end of
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Figure 6. Impaired Recruitment of Centriole Distal End Proteins in JS (V194A) and JATD (A199P) Mutant RPE-1 Cells
(A) CEP164 localizes to the distal end of the mother centriole in control, V194A, and A199P mutant RPE-1 cell lines. Cells were stained by antibodies against
CEP164 and g-tubulin. Images correspond to maximum intensity projections of confocal micrographs. Insets depict high (33) magnification of centrosomes.
Scale bars, 5 mm.
(B) The number of CEP164 foci is reduced in V194A cells. Asynchronous (non-mitotic) cells are expected to have a single CEP164 focus fromG1 through S phase,
followed by the appearance of two foci in G2.
(C) Centrosomal CEP164 levels are reduced in both V194A and A199P mutant cell lines. Quantification of total centrosomal CEP164 levels from maximum in-
tensity projections obtained in the experiment shown in (A). Quantification was performed as in Figure 4D. Swarm plots represent values from single cells, with
horizontal linesmarking themedian, and error bars represent SD. p valueswere obtained from an unpaired, two-tailed Student’s t test (**p < 0.005, ****p < 0.0001).
Similar results were obtained from two independent experiments.
(D) TALPID3 localizes to the distal ends of mother and daughter centrioles in control, V194A, and A199P mutant RPE-1 cell lines. Cells stained by antibodies
against TALPID3 and g-tubulin. Images correspond to maximum intensity projections of confocal micrographs. Insets show numbered centrosomes at high (43)
magnification. Scale bars, 5 mm.
(legend continued on next page)
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mother centrioles approximately coincides with the formation of
the ciliary vesicle and is a prerequisite for axoneme extension
(Lu et al., 2015; Spektor et al., 2007). As expected, in ciliated con-
trol cells, CP110 was observed only on daughter centrioles (Fig-
ure S7C). By contrast, similarly to cycling cells (Figure S5C),most
serum-starvedV194A, but not A199P, cells contained twoCP110
foci and no cilia (Figure S7C), indicative of a defect in CP110
removal from V194A mutant mother centrioles.
DISCUSSION
Cilia are essential cell organelles with multiple functions in vivo
such as fluid movement, sensing, and signaling. Mutations that
disturb the formation or function of cilia give rise to ciliopathies,
a diverse group of genetic diseases that affect multiple organs
and tissues. Ciliopathic mutations mainly target components of
the cilium or the transition zone between basal bodies and cilia,
but mutations in core centriolar proteins are rare, with CEP120
and possibly POC1A and PLK4 being the only examples of
centriole assembly proteins so far (Martin et al., 2014; Roosing
et al., 2016; Shaheen et al., 2012, 2015). Partly because of the
lack of high-resolution structural information about the mutated
proteins, the mechanisms by which these mutations cause cilio-
pathies are poorly understood.
Here,we show that the ciliopathicmutations V194AandA199P
within the second C2 domain (C2B) of CEP120 affect residues
that point toward its hydrophobic core and lead to its reduced
thermostability in vitro and decreased cellular and centrosomal
CEP120 levels in vivo. Using patient-derived fibroblast cells (but
not when using zebrafish as a model), Shaheen and colleagues
(Shaheen et al., 2015) detected altered centrosome numbers in
the A199P mutant. However, as judged by the presence of the
proximal centriole marker CEP152, we found centriole duplica-
tion to be largely normal in one V194A cell clone and in two
independently derived A199P clones. In contrast, both mutants
displayeddefects related to thedistal endof centrioles, as judged
by a reduction of CEP164 and TALPID3 intensities; a decrease
was also noted in the broad distal-end marker centrin in the
V194A mutant. Remarkably, these results suggest that centriole
assembly can continue unhindered for many cellular generations
in the presence of abnormal distal ends. The absence of a
centriole duplication phenotype may also explain why neither
JS nor JATDmutations in CEP120 seem to cause primary micro-
cephaly or primordial dwarfism, human disorders associated
with mutations in core centriolar proteins (Chavali et al., 2014).
Both JS and JATD mutants are strongly defective in cilia for-
mation, possibly due to the aforementioned impaired retention/
recruitment of distal-end proteins to the mother centrioles that
play major roles in cilia formation (Graser et al., 2007a; Kobaya-
shi et al., 2014; Prosser and Morrison, 2015). Recent work has
also implicated the daughter centriole in promoting ciliogenesis
(Loukil et al., 2017) through destabilization of CP110 on mother(E) Centrosomal TALPID3 levels are reduced in both V194A and A199Pmutant RPE
intensity projections obtained in the experiment shown in (D). Quantification was p
horizontal lines marking the median, and error bars represent SD. p values were o
Similar results were obtained from three independent experiments.
See also Figures S4–S6.
2814 Cell Reports 23, 2805–2818, May 29, 2018centrioles, a process that could require daughter-centriole-
associated CEP120. Mechanistically, we cannot distinguish be-
tween cilia formation being impeded in the mutants by the
decrease in CEP120 levels, compromised C2B domain function,
or a combination of both factors. Intriguingly, the extent to which
cilia formation was impaired correlated with the degree of
CEP120 reduction in both mutants, arguing that the phenotypes
manifest through the reduction of the centrosomal CEP120 pool.
Such a scenario is consistent with the fact that JS and JATD
mutant CEP120 are still able to drive centriole extension when
overexpressed (Figure S6A). If CEP120 reduction were the sole
cause of the ciliation phenotype, then this would suggest that cil-
iogenesis requires higher CEP120 levels than centriole biogen-
esis. However, the amount of CEP120 in individual centrosomes
does not necessarily correlate with their ability to ciliate (Fig-
ure S7A). Thus, the mutations are likely to interfere with addi-
tional aspects of CEP120 function.
Intriguingly, the V194A JS and A199P JATDmutations have an
analogous negative impact on the thermodynamic stability of
CEP120 C2B in vitro and ciliogenesis in vivo. These results raise
the question of why they provoke diseases with distinct pheno-
types. The clinical features of JS and JATD can overlap (Lehman
et al., 2010; Malicdan et al., 2015; Tuz et al., 2014), with one of
the JATD patients described by Shaheen and colleagues (Sha-
heen et al., 2015) also displaying the ‘‘molar tooth’’ sign in brain
magnetic resonance imaging (MRI) typically found in JS. Thus,
the genetic backgrounds of the affected patients might modify
the clinical manifestation of the mutations. A more detailed un-
derstanding of how JATD and JS arise from both mutations will
require the identification of CEP120 C2B binding partner(s) and
how their binding is affected in the mutants. Furthermore, to pro-
vide a clearer understanding of the impact of CEP120 mutations
on development and homeostasis, it will be important to estab-
lish how these mutations influence the efficiency of ciliogenesis
and the functionality of cilia in tissues relevant to JATD (cartilage
and bone) and JS (neural).
C2 domains perform a variety of functions. While some bind to
lipids (through Ca2+-coordinating top loops or so-called cationic
b-grooves; Cho and Stahelin, 2006), others are involved in pro-
tein-protein interactions (Corbalan-Garcia and Go´mez-Ferna´n-
dez, 2014; Remans et al., 2014). Our structures revealed neither
complexed Ca2+ nor potential Ca2+-coordinating top loop resi-
dues or cationic b-grooves. Furthermore, a CEP120-GFP frag-
ment containing its three C2 domains did not show membrane
enrichment when overexpressed in cells (Figure S1D). Thus, the
CEP120C2domains probably play a role as protein-protein inter-
action modules. Prime candidates for interaction interfaces in
these domains are the regions defined by strands 3 and 4 at the
edges of their b sandwich that constitute their most conserved
parts (Figure S1E). Strikingly, other structurally characterized
C2 domains engage their binding partners using exactly the
same interface (Figure S1F). Both residues V194 and A199,-1 cell lines. Quantification of total centrosomal TALPID3 levels frommaximum
erformed as in Figure 4D. Swarm plots represent values from single cells, with
btained from a two-tailed Mann-Whitney U test (***p < 0.0005, ****p < 0.0001).
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targeted by the JS and JATD mutations, are located near
this putative interface in CEP120 C2B (Figures 1, 2B, and 2C)
and might disrupt its function as suggested by our in vitro
experiments.
Together with a recent report (Sharma et al., 2018), our results
make inroads into a mechanistic understanding of CEP120 by
establishing its domain organization into a C-terminal coiled-
coil domain and three N-terminal C2 domains that appear to
be organized as beads on a string. While the C2A domain of
CEP120 interacts with tubulin and promotes microtubule forma-
tion (Lin et al., 2013; Sharma et al., 2018), our results suggest that
the C2B domain does not directly contribute to this activity, as
neither JS nor JATD mutations in C2B abolished the ability of
CEP120 to cause centriole overextension when overexpressed
in cells (Figure S6A). Thus, C2B might instead interact with other
factors that either synergize with C2A function or regulate addi-
tional aspects of centriole assembly. Using amodified BioID pro-
cedure, we identified several centrosomal proteins as putative
proximity interactors of CEP120 C2B, including CEP350, centro-
bin, CP110, TALPID3, and KIF24, all of which are involved in cil-
iogenesis (Kobayashi et al., 2011, 2014; Mojarad et al., 2017;
Ogungbenro et al., 2018; Spektor et al., 2007; Yin et al., 2009)
(Figure S6B; Table S4). However, it remains to be established
whether these factors show a direct interaction with CEP120
C2B and whether such an interaction would be affected by JS
and JATDmutations. Overexpressed, tagged versions of centro-
bin and CEP120, for example, showed co-immunoprecipitation
from cell extracts that was impaired by C2B deletion, but not
by the JS or JATD mutations (Figure S6C). However, these
immunoprecipitations were carried out at 4C, whereas the
deleterious effects of the point mutations on CEP120 C2B ther-
mostability were particularly pronounced at 35C–37C. Since
Centrobin intensity at centrosomes does not appear grossly
altered in the JS and JATD mutant cell lines (Figure S7D), the
physiological relevance of this putative interaction remains to
be determined. Intriguingly, mutations in the CEP120 interactor
TALPID3 (Wu et al., 2014) can give rise to hybrid ciliopathies
with JATD- and JS-like features (Malicdan et al., 2015).We found
that the V194A and A199P mutations in CEP120 both impaired
normal recruitment of TALPID3 to centriole distal ends, and
thus, insufficient centrosomal TALPID3 could contribute to
CEP120-linked ciliopathies.Figure 7. Ciliogenesis Is Markedly Reduced by the JS (V194A) and JAT
(A) Cilia numbers are much reduced in V194A and A199Pmutant RPE-1 cell lines.
membrane protein ARL13b and acetylated a-tubulin. Images correspond to max
(B) Quantification of the experiment shown in (A). Number of cilia was counted in
(DCEP120) RPE-1 cell clones.
(C) TALPID3 is detectable in the basal bodies of ciliated V194A, A199P, and contro
against TALPID3 and acetylated-a-tubulin. Images to the right show basal bodies
projections of confocal micrographs. Scale bars, 5 mm.
(D) TALPID3 localizes to the distal ends of mother and daughter centrioles in con
(24 hr) RPE-1 cells were stained by antibodies against TALPID3 and g-tubulin. Ins
identification of centrosomes. Images correspond to maximum intensity projecti
(E) Centrosomal TALPID3 levels are reduced in V194A mutant RPE-1 cell lines
projections obtained in experiment shown in (D). Quantification was performed a
lines marking the median, and error bars represent SD. p values were obtained f
results were obtained from two biological replicates.
See also Figures S4, S6, and S7 and Table S4.
2816 Cell Reports 23, 2805–2818, May 29, 2018In summary, our study elucidates the structural organization of
CEP120, its perturbation caused by two ciliopathy-associated
mutations in vitro, and the consequences of this perturbation
on CEP120 and centriole function in vivo. Furthermore, this
work lays the foundation for future research aimed at obtaining
a full mechanistic understanding of the role of CEP120 in cilio-
genesis, which will undoubtedly provide vital insight into the dis-
ease mechanisms of JS and the devastating ciliopathy JATD.
EXPERIMENTAL PROCEDURES
Please refer to the Supplemental Experimental Procedures for a full descrip-
tion of the experimental procedures used.
Protein Crystallization
D. rerioCEP1201–136 (C2A) was crystallized by the vapor diffusion method with
sitting drops (100 nL protein solution + 100 nL reservoir solution) in the JBS 1
screen (JenaBioScience) with a reservoir solution of 100 mM HEPES (pH 7.5),
200 mM MgCl2, and 30% (v/v) PEG-400 at 19
C. Crystals were mounted in
reservoir solution after 1 day and frozen in liquid nitrogen.
O.n. CEP120165–353 G307S and A200P + G307S (C2B) were crystallized in a
similar setup at 19C with a reservoir solution of 100 mM MES buffer (pH 6.1),
29% (v/v) PEG-400 (native, G307S), or 100 mM MES (pH 6.0), 26% (v/v)
PEG-400 (SeMet, G307S), and optionally 2 mM DTT (SeMet, G307S) or with
a reservoir solution of 100 mM Tris (pH 8.0) and 30% (w/v) PEG-6000 (native
A200P + G307S, Grid Screen PEG-6000, Hampton Research). Crystals were
mounted in reservoir solution after 6 days (native, G307S) or 3 days (SeMet,
G307S) or were mounted after 10 days in 100 mM Tris-CL (pH 8.5), 25%
(w/v) PEG-6000, and 25% glycerol (A200P + G307S).
O.n. CEP120165–353 WT was crystallized at 19C in a similar setup in 96-well
plates containing a linear gradient of reservoir solutions from 30% (v/v) PEG-
400, 100 mM MES (pH 6.0) (column 1) to 30% (v/v) PEG-400, 100 mM MES
(pH 7.0) (column 12). Crystals were mounted in reservoir solution after
10 days from columns 6–8. All crystals were frozen in liquid nitrogen.
M. musculus CEP120436-634 (C2C) was crystallized at 19C by the vapor
diffusion method in sitting drops (1 mL protein solution + 1 mL reservoir solution)
with a reservoir solution of 50 mM MES (pH 5.2 [native] or pH 6.1 [SeMet]),
10 mM MgCl2, 200 mM KCl, and 5% (native) or 6% (SeMet) (w/v) PEG-8000.
Crystals were mounted in reservoir solution without PEG-8000 containing
30% PEG-400 after 4 days (native) or 5 days (SeMet) and frozen in liquid
nitrogen.
Generation of CEP120 Variants in RPE-1 Cells by Genome
Engineering
A199P and V194A RPE-1 p53/ cells were prepared using a CRISPR-Cas9
method following published protocols (Ran et al., 2013). See Supplemental
Experimental Procedures for a full description.D (A199P) Mutations In Vivo
Serum-starved (48 hr) RPE-1 cells were stained by antibodies against the ciliary
imum intensity projections of confocal micrographs. Scale bars, 5 mm.
serum-starved (48 hr or 72 hr) A199P#1, A199P#2, V194A, and CEP120 null
l RPE-1 cell lines. Serum-starved (24 hr) RPE-1 cells were stained by antibodies
and cilia at high (23) magnification. Images correspond to maximum intensity
trol and A199P mutant RPE-1 cell lines, but not in V194A cells. Serum-starved
ets show centrosomes at high (43) magnification. Numbering is included to aid
ons of confocal micrographs. Scale bars, 5 mm.
. Quantification of total centrosomal TALPID3 levels from maximum intensity
s in Figure 4D. Swarm plots represent values from single cells, with horizontal
rom an unpaired, two-tailed Student’s t test (*p < 0.05, ****p < 0.0001). Similar
Image Acquisition
Imaging of fixed cells was performed on Leica DMi8 scanning confocal micro-
scope. Cells were imaged with a harmonic compound plan apochromat
(HC PL APO) CS2 63 or 1003 1.4 numerical aperture oil-immersion Leica
objectives. Images shown throughout the manuscript represent maximum in-
tensity projections of z sections taken every 0.3 mm. Images in Figure S6Awere
taken across 0.45 mm. The imaging range was set to include the entirety of
each individual centrosome within a field. Images of any individual figure
were acquired using the same settings and were imported into Fiji image pro-
cessing package, Volocity 6.3 (Perkin Elmer) or Photoshop CS6 (Adobe). For
counting centrin-3 and CEP164 foci, maximum intensity projections of z sec-
tions taken every 0.1 mm were used.
Statistical Analysis
Statistical analyses and preparation of graphs were performed using Prism7
(GraphPad Software). Details of the used statistical tests and number of exper-
imental repeats (n values) are reported for each dataset in the figures and figure
legends.
DATA AND SOFTWARE AVAILABILITY
The accession numbers for the X-ray crystallographic structures reported in
this paper are PDB: 6EWL, 6EWG, 6EWH, 6EWI, and 6EWP.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and four tables and can be found with this article online at
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